Equity Analyst, LightStream Research

Shifara Samsudeen, FCMA, CGMA

Equity Analyst

Long-Short Analysis on Japan, Asia and the World

LightStream Research

LightStream conducts quantitatively rigorous and data-driven analysis with a focus on Japan and Asia.

We consistently cover the Tech, Consumer and Industrial sectors, and provide ECM and Events coverage more broadly.

We supplement traditional qualitative insights from company relationships with a robust quantitative foundation that examines as much historical data as is available.
We further refine the accuracy of our insights and calls through the use of alternative data to flesh out current trends, and through a valuation framework that emphasises non-superficial peer group selection and a proper attempt to understand the metrics and changes that have driven security valuations in the past.

Equity Bottom-Up

<a href="https://www.smartkarma.com/entities/olympus-corp/overview" target="_blank" rel="noopener">Olympus (7733 JP)</a> reported 1QFY03/2020 results on Friday (02nd August 2019) which saw a marginal YoY improvement in company revenue while operating profit increased 18% YoY on a comparable basis (excluding one-off expenses in 1QFY03/2019). On a segmental basis, the revenues of the key business segments increased YoY while the Imaging business continued to post decline in revenue coupled with operating losses of JPY2.3bn. Olympus has not revised its previous guidance for FY03/2020E which expects 0.8% YoY growth in revenue alongside JPY90bn in operating profit compared to JPY28.3bn in FY03/2019. The company is expecting its key businesses to continue to grow while it focuses on reorganising its Imaging business in an attempt to turnaround its deteriorating performance. We believe the company estimates for FY03/2020E are conservative and is in line to meet its target.We discuss the details below.

Olympus (7733 JP) reported 1QFY03/2020 results on Friday (02nd August 2019) which saw a marginal YoY improvement in company revenue while operating profit increased 18% YoY on a comparable basis (excluding one-off expenses in 1QFY03/2019). On a segmental basis, the revenues of the key business segments increased YoY while the Imaging business continued to post decline in revenue coupled with operating losses of JPY2.3bn. Olympus has not revised its previous guidance for FY03/2020E which expects 0.8% YoY growth in revenue alongside JPY90bn in operating profit compared to JPY28.3bn in FY03/2019. The company is expecting its key businesses to continue to grow while it focuses on reorganising its Imaging business in an attempt to turnaround its deteriorating performance. We believe the company estimates for FY03/2020E are conservative and is in line to meet its target.We discuss the details below.

Olympus: Key Businesses Continue to Grow; Shares Are Fairly Valued

'Quantamental' Japan Specialist, LightStream Research

Campbell Gunn

'Quantamental' Japan Specialist

ja research

ja research is an independent research platform focused exclusively on Japanese equities. Leveraging data and graphic analysis provided by Japan Analytics, we provide insights on small and medium-sized companies that have been ignored by the sell-side as well as challenging conventional wisdom on larger companies. We also offer analyst and corporate access, the latter with translation if required. 

Quantitative Analysis

<div class="content-caption">
<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/093/001/original/2019-07-13_16-16-31.png?1563002212" class="editor-image img-responsive" data-smartkarma-image-id="93001"></figure><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/093/005/original/2019-07-13_16-25-24.png?1563002742" class="editor-image img-responsive" data-smartkarma-image-id="93005"></figure>Source: Japan Analytics
</div>MOVING AVERAGE BREAKOUT - Japanese equities have now risen by 5.1% since the low of 4th June and, since July 1st, the Total Market Value has exceeded the 50-Day Moving Average for the first time since 26th April. Over the last two weeks, the Total Market Value has gained 1.7% in both Yen and US dollar times. For the previous twelve months, the equity market has moved in line with the US dollar/Japanese Yen exchange rate. It remains to be seen how the 'gap' that has opened up in the last month will be closed. Any further strength in the Yen from current levels will likely see the market slip below the 50-Day Moving Average again.<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/093/020/original/2019-07-14_06-28-16.png?1563053334" class="editor-image img-responsive" data-smartkarma-image-id="93020"></figure><div class="content-caption">
<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/093/024/original/2019-07-14_06-45-29.png?1563054338" class="editor-image img-responsive" data-smartkarma-image-id="93024"></figure> Source: Japan Analytics</div>VALUE TRADED RATIO - The Value Traded Ratio (Value Traded/Total Market Value) has seen two new eighteen-month lows. If the three days around Christmas are excluded, the current apathy towards Japanese equities is the most extreme since 2012 and is confirmed by recent BAML investor surveys. In the past, such periods of inactivity (marked"▲"above)  have preceded changes in market direction, more often upwards rather than downwards and suggest the current rally has more 'legs'. <div class="content-caption">
<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/093/025/original/2019-07-14_06-47-40.png?1563054585" class="editor-image img-responsive" data-smartkarma-image-id="93025"></figure> Source: Japan Analytics</div>TORAKU INDEX - Conversely, the Toraku advance/decline index is suggesting a degree of caution having breached the 120 'overbought' line for only the third time in eighteen months. Combining this analysis with the Value Traded Ratio, there is scope for a short-term upward move akin to that of October 2018 to be followed by a sharper downward trend into the autumn.  <div class="content-caption">
<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/093/026/original/2019-07-14_06-54-51.png?1563054906" class="editor-image img-responsive" data-smartkarma-image-id="93026"></figure> Source: Japan Analytics</div>VOLUME SCORE TIMELINE - The lull in market turnover is confirmed in the greener 'bias' in our Sector volume timeline. The Retail and Restaurant Sectors are hot as we are in the middle of the quarterly results announcements for February/May/August/November year-end companies. REITs remain the 'go-to' defensive Sector while the Information Technology and Internet Sectors are the 'tema-du-jour' - to mix language metaphors. The 'untouchables' are Metals, Banks, UtilitiesTransportation,  and Multi-Industry.<div class="content-caption">
<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/093/028/original/2019-07-14_07-31-40.png?1563057109" class="editor-image img-responsive" data-smartkarma-image-id="93028"></figure> Source: Japan Analytics</div>3-MONTH SECTOR CONTRIBUTION - Over the last three months, a long Telcos/short Autos strategy would have yielded 82 basis points of performance. The Retail Sector has responded well to the results released so far led by drugstores <a href="https://www.smartkarma.com/entities/welcia-holdings-co-ltd" target="_blank" data-smartkarma-citation="entities:20895:1" rel="noopener">Welcia (3141 JP)</a> and <a href="https://www.smartkarma.com/entities/tsuruha-holdings-inc" target="_blank" data-smartkarma-citation="entities:9536:1" rel="noopener">Tsuruha (3391 JP), </a><a href="https://www.smartkarma.com/entities/fast-retailing-co-ltd" target="_blank" data-smartkarma-citation="entities:751:1" rel="noopener">Fast Retailing (9983 JP)</a><a href="https://www.smartkarma.com/entities/tsuruha-holdings-inc" target="_blank" data-smartkarma-citation="entities:9536:1" rel="noopener">, and </a><a href="https://www.smartkarma.com/entities/lawson-inc" target="_blank" data-smartkarma-citation="entities:1040:1" rel="noopener">Lawson (2651 JP)</a>. Electrical Equipment has suffered from weakness in component stocks <a href="https://www.smartkarma.com/entities/alps-alpine-co-ltd" target="_blank" data-smartkarma-citation="entities:12001:1" rel="noopener">Alps Alpine (6770 JP)</a> (-38% over one year), <a href="https://www.smartkarma.com/entities/murata-manufacturing-co-ltd" target="_blank" data-smartkarma-citation="entities:11649:1" rel="noopener">Murata (6981 JP)</a> (see <a href="https://www.smartkarma.com/profiles/scott-foster" target="_blank" data-smartkarma-citation="accounts:1134" rel="noopener">Scott Foster</a>'s <a href="https://www.smartkarma.com/insights/murata-mfg-6981-jp-buy-on-decline-for-the-long-term" target="_blank" data-smartkarma-citation="insights:30919" rel="noopener">(Buy on Decline for the Long Term</a>), and <a href="https://www.smartkarma.com/entities/taiyo-yuden-co-ltd" target="_blank" data-smartkarma-citation="entities:9924:1" rel="noopener">Taiyo Yuden (6976 JP)</a>, while <a href="https://www.smartkarma.com/entities/smc-corp" target="_blank" data-smartkarma-citation="entities:20866:1" rel="noopener">SMC (6273 JP)</a>, <a href="https://www.smartkarma.com/entities/fanuc-corp" target="_blank" data-smartkarma-citation="entities:752:1" rel="noopener">Fanuc (6954 JP)</a>, and <a href="https://www.smartkarma.com/entities/komatsu-ltd" target="_blank" data-smartkarma-citation="entities:8416:1" rel="noopener">Komatsu (6301 JP)</a> have weighed on the Machinery Sector.<div class="content-caption">
<figure class="editor-figure mceNonEditable"><figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/093/031/original/2019-07-14_07-44-47.png?1563057897" class="editor-image img-responsive" data-smartkarma-image-id="93031"></figure></figure> Source: Japan Analytics</div>SECTOR SCORE MATRIX - Arranging our cap-weighted Sector Relative Price Scores and Results &amp; Revisions Scores in a four-quadrant matrix whose extremes are Contrarian Sell, Contrarian Buy, Unrequited Growth, and Ex-Growth suggest profit-taking in Information Technology (<a href="https://www.smartkarma.com/entities/obic-co-ltd" target="_blank" data-smartkarma-citation="entities:1273:1" rel="noopener">OBIC (4684 JP)</a>, Other Commerical Products (<a href="https://www.smartkarma.com/entities/hoya-corp" target="_blank" data-smartkarma-citation="entities:8990:1" rel="noopener">Hoya Corp (7741 JP)</a>, and Commercial Services (<a href="https://www.smartkarma.com/entities/recruit-holdings-co-ltd" target="_blank" data-smartkarma-citation="entities:15070:1" rel="noopener">Recruit 6098 JP).</a> We are not contrarian enough to fall into the banking 'trap', however, the Metals Sector may offer some 'crumbs' of comfort for those in need of a deep value 'fix' (<a href="https://www.smartkarma.com/entities/nippon-steel-sumitomo-metal-corp" target="_blank" data-smartkarma-citation="entities:961:1" rel="noopener">Nippon Steel &amp; Sumitomo Metal (5401 JP)</a>) <div class="content-highlight">In the DETAIL section below, we will review Sector performance, scores and valuation in more detail, as well as Company Results &amp; Revisions and individual stock performance over the previous two weeks, as well as adding some brief comments on <a href="https://www.smartkarma.com/entities/welcia-holdings-co-ltd" target="_blank" data-smartkarma-citation="entities:20895:1" rel="noopener">Welcia (3141 JP)</a>, <a href="https://www.smartkarma.com/entities/daiseki-co-ltd" target="_blank" data-smartkarma-citation="entities:2330:1" rel="noopener">Daiseki (9793 JP), </a><a href="https://www.smartkarma.com/entities/yaskawa-electric-corp" target="_blank" data-smartkarma-citation="entities:2458:1" rel="noopener">Yaskawa Electric (6506 JP), </a><a href="https://www.smartkarma.com/entities/pola-orbis-holdings-inc" target="_blank" data-smartkarma-citation="entities:2287:1" rel="noopener">Pola Orbis (4927 JP)</a>, <a href="https://www.smartkarma.com/entities/sekisui-house-ltd" target="_blank" data-smartkarma-citation="entities:4508:1" rel="noopener">Sekisui House (1928 JP)</a>, <a href="https://www.smartkarma.com/entities/keyence-corp" target="_blank" data-smartkarma-citation="entities:3077:1" rel="noopener">Keyence (6861 JP)</a>, <a href="https://www.smartkarma.com/entities/japan-post-insurance-co-ltd" target="_blank" data-smartkarma-citation="entities:840:1" rel="noopener">Japan Post Insurance (7181 JP)</a>, and <a href="https://www.smartkarma.com/entities/obic-co-ltd" target="_blank" data-smartkarma-citation="entities:1273:1" rel="noopener">Obic (4684 JP)</a>.</div>


Source: Japan Analytics
MOVING AVERAGE BREAKOUT - Japanese equities have now risen by 5.1% since the low of 4th June and, since July 1st, the Total Market Value has exceeded the 50-Day Moving Average for the first time since 26th April. Over the last two weeks, the Total Market Value has gained 1.7% in both Yen and US dollar times. For the previous twelve months, the equity market has moved in line with the US dollar/Japanese Yen exchange rate. It remains to be seen how the 'gap' that has opened up in the last month will be closed. Any further strength in the Yen from current levels will likely see the market slip below the 50-Day Moving Average again.
 Source: Japan AnalyticsVALUE TRADED RATIO - The Value Traded Ratio (Value Traded/Total Market Value) has seen two new eighteen-month lows. If the three days around Christmas are excluded, the current apathy towards Japanese equities is the most extreme since 2012 and is confirmed by recent BAML investor surveys. In the past, such periods of inactivity (marked"▲"above)  have preceded changes in market direction, more often upwards rather than downwards and suggest the current rally has more 'legs'. 
 Source: Japan AnalyticsTORAKU INDEX - Conversely, the Toraku advance/decline index is suggesting a degree of caution having breached the 120 'overbought' line for only the third time in eighteen months. Combining this analysis with the Value Traded Ratio, there is scope for a short-term upward move akin to that of October 2018 to be followed by a sharper downward trend into the autumn.  
 Source: Japan AnalyticsVOLUME SCORE TIMELINE - The lull in market turnover is confirmed in the greener 'bias' in our Sector volume timeline. The Retail and Restaurant Sectors are hot as we are in the middle of the quarterly results announcements for February/May/August/November year-end companies. REITs remain the 'go-to' defensive Sector while the Information Technology and Internet Sectors are the 'tema-du-jour' - to mix language metaphors. The 'untouchables' are Metals, Banks, UtilitiesTransportation,  and Multi-Industry.
 Source: Japan Analytics3-MONTH SECTOR CONTRIBUTION - Over the last three months, a long Telcos/short Autos strategy would have yielded 82 basis points of performance. The Retail Sector has responded well to the results released so far led by drugstores Welcia (3141 JP) and Tsuruha (3391 JP), Fast Retailing (9983 JP), and Lawson (2651 JP). Electrical Equipment has suffered from weakness in component stocks Alps Alpine (6770 JP) (-38% over one year), Murata (6981 JP) (see Scott Foster's (Buy on Decline for the Long Term), and Taiyo Yuden (6976 JP), while SMC (6273 JP), Fanuc (6954 JP), and Komatsu (6301 JP) have weighed on the Machinery Sector.
 Source: Japan AnalyticsSECTOR SCORE MATRIX - Arranging our cap-weighted Sector Relative Price Scores and Results &amp; Revisions Scores in a four-quadrant matrix whose extremes are Contrarian Sell, Contrarian Buy, Unrequited Growth, and Ex-Growth suggest profit-taking in Information Technology (OBIC (4684 JP), Other Commerical Products (Hoya Corp (7741 JP), and Commercial Services (Recruit 6098 JP). We are not contrarian enough to fall into the banking 'trap', however, the Metals Sector may offer some 'crumbs' of comfort for those in need of a deep value 'fix' (Nippon Steel &amp; Sumitomo Metal (5401 JP)) In the DETAIL section below, we will review Sector performance, scores and valuation in more detail, as well as Company Results &amp; Revisions and individual stock performance over the previous two weeks, as well as adding some brief comments on Welcia (3141 JP), Daiseki (9793 JP), Yaskawa Electric (6506 JP), Pola Orbis (4927 JP), Sekisui House (1928 JP), Keyence (6861 JP), Japan Post Insurance (7181 JP), and Obic (4684 JP).

🇯🇵 JAPAN • Market Update - Levitating on Thin Air

INTRODUCTION - Following on from our review of Spring Market  &amp; Sector Aggregates &amp; Scores <a href="https://www.smartkarma.com/insights/japan-spring-results-revisions-market-sector-aggregates-scores-2nd-quarter" target="_blank" data-smartkarma-citation="insights:29938">Insight</a>, this Insight will cover the cap-weighted Results &amp; Revision Scores for the 328 Peer Groups that comprise our 30 Sectors and provide greater depth to our analysis of current business trends.  Peer Group definitions reflect both standard SIC/GICS classifications as well as local market conventions. The number of constituents and market capitalisation for each Peer Group varies widely. A full list of the Peer Groups within each sector is provided below. As an appetiser, the charts below show the top and bottom ten Peer Groups ranked by Results &amp; Revision Score.<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/088/989/original/2019-05-28_11-43-58.png?1559011506" class="editor-image img-responsive" data-smartkarma-image-id="88989"></figure><div class="content-caption">
<figure class="editor-figure mceNonEditable"><img src="https://static-prod.smartkarma.com/images/media/000/088/991/original/2019-05-28_11-46-04.png?1559011726" class="editor-image img-responsive" data-smartkarma-image-id="88991"></figure>Source: Japan Analytics
</div><div class="content-highlight">In the DETAIL section below, we list the top and bottom twenty Peer Groups ranked by Results &amp; Revision Score and the top and bottom twenty most-changed over the last three months as well the most optimistic and most pessimistic.  </div>

INTRODUCTION - Following on from our review of Spring Market  &amp; Sector Aggregates &amp; Scores Insight, this Insight will cover the cap-weighted Results &amp; Revision Scores for the 328 Peer Groups that comprise our 30 Sectors and provide greater depth to our analysis of current business trends.  Peer Group definitions reflect both standard SIC/GICS classifications as well as local market conventions. The number of constituents and market capitalisation for each Peer Group varies widely. A full list of the Peer Groups within each sector is provided below. As an appetiser, the charts below show the top and bottom ten Peer Groups ranked by Results &amp; Revision Score.
Source: Japan Analytics
In the DETAIL section below, we list the top and bottom twenty Peer Groups ranked by Results &amp; Revision Score and the top and bottom twenty most-changed over the last three months as well the most optimistic and most pessimistic.  

🇯🇵 JAPAN • Spring Results & Revision Scores - Peer Groups

On Thursday (16th May), <a href="https://www.smartkarma.com/entities/fujifilm-holdings-corp/overview" target="_blank">Fujifilm (4901 JP)</a> announced that it has entered into an agreement to acquire medwork GmbH, headquartered in Bayern, Germany. medwork develops, manufactures and markets instruments for therapeutic and diagnostic endoscopy and following the acquisition, medwork will become a 100%-owned subsidiary of Fujifilm. The company has not provided more details regarding the deal. However, according to sources, Fujifilm will be paying close to JPY8-9bn for medwork. We expect the medwork acquisition to complement Fujifilm’s existing endoscopes business.
This comes as a part of Fujifilm’s focus on rapidly expanding its footprint in the growing healthcare sector. In March 2019, the company also announced the acquisition of Biogen Manufacturing, a manufacturing subsidiary of Biogen (Denmark) which is expected to strengthen Fujifilm’s Bio CDMO business.

On Thursday (16th May), Fujifilm (4901 JP) announced that it has entered into an agreement to acquire medwork GmbH, headquartered in Bayern, Germany. medwork develops, manufactures and markets instruments for therapeutic and diagnostic endoscopy and following the acquisition, medwork will become a 100%-owned subsidiary of Fujifilm. The company has not provided more details regarding the deal. However, according to sources, Fujifilm will be paying close to JPY8-9bn for medwork. We expect the medwork acquisition to complement Fujifilm’s existing endoscopes business.
This comes as a part of Fujifilm’s focus on rapidly expanding its footprint in the growing healthcare sector. In March 2019, the company also announced the acquisition of Biogen Manufacturing, a manufacturing subsidiary of Biogen (Denmark) which is expected to strengthen Fujifilm’s Bio CDMO business.

Fujifilm Continues to Increase Its Focus on Healthcare Sector Through the Acquisition of Medwork

<ul>
<li>
<a href="https://www.smartkarma.com/entities/olympus-corp/overview" target="_blank">Olympus Corporation (7733 JP)</a> reported its full-year FY03/19 results on Friday (10th May). The company reported 0.9% YoY growth in revenue for FY03/19 which was a touch above its own estimate and consensus. However, the OP for the year declined by 65.1% YoY while it fell below guidance as well as consensus by 35.7% and 35.1% respectively. The OP for the year was affected by several one-time expenditures and excluding these one-off items of JPY40.9bn, the OP declined by 14.6% YoY resulting in an OPM of 8.7% compared to the 3.6% reported by the company.</li>
<li>On a segmental basis, the revenues of the Medical segment grew 2.9% YoY in FY03/19 while OP declined 8.1% YoY during the year. The growth in revenue was mainly driven by Surgical and Endotherapy businesses while the OP decline was mainly due to the costs associated with the plea agreement with the US DOJ.</li>
<li>The Scientific Solutions segment saw its revenue growing 4.2% YoY while its OP increased 26.6% YoY for FY03/19. The strong performance of the segment could be attributed to growth in sales of biological microscopes for hospital and life science research in North America and China.</li>
<li>The Imaging Segment which has been struggling due to the contracting digital camera market, reported yet again another quarter of revenue decline as the segment’s revenue was under pressure due to intensifying competition in the mirrorless camera market.</li>
<li>For FY03/20, Olympus is forecasting revenue to grow 0.8% YoY to JPY800bn while it expects the OP to grow by more than three-fold to JPY90bn compared to JPY28.3bn reported for FY03/18. When compared to the adjusted OP of JPY69.2bn (excluding the one-off expenses), the OP will grow by 30.1% YoY.</li>
<li>Olympus is currently trading at JPY1,251 per share which we believe is overvalued based on our valuation. We believe such a premium is not justified given the governance related issues and the scandals currently faced by the company. Though we expect the company financials to improve, we expect the transformation plan to take a long-time to deliver meaningful changes in the way the company conducts itself.  In our view, the potential for a transformation in governance and business practices is already fully-discounted in the share price.</li>
</ul>



Olympus Corporation (7733 JP) reported its full-year FY03/19 results on Friday (10th May). The company reported 0.9% YoY growth in revenue for FY03/19 which was a touch above its own estimate and consensus. However, the OP for the year declined by 65.1% YoY while it fell below guidance as well as consensus by 35.7% and 35.1% respectively. The OP for the year was affected by several one-time expenditures and excluding these one-off items of JPY40.9bn, the OP declined by 14.6% YoY resulting in an OPM of 8.7% compared to the 3.6% reported by the company.
On a segmental basis, the revenues of the Medical segment grew 2.9% YoY in FY03/19 while OP declined 8.1% YoY during the year. The growth in revenue was mainly driven by Surgical and Endotherapy businesses while the OP decline was mainly due to the costs associated with the plea agreement with the US DOJ.
The Scientific Solutions segment saw its revenue growing 4.2% YoY while its OP increased 26.6% YoY for FY03/19. The strong performance of the segment could be attributed to growth in sales of biological microscopes for hospital and life science research in North America and China.
The Imaging Segment which has been struggling due to the contracting digital camera market, reported yet again another quarter of revenue decline as the segment’s revenue was under pressure due to intensifying competition in the mirrorless camera market.
For FY03/20, Olympus is forecasting revenue to grow 0.8% YoY to JPY800bn while it expects the OP to grow by more than three-fold to JPY90bn compared to JPY28.3bn reported for FY03/18. When compared to the adjusted OP of JPY69.2bn (excluding the one-off expenses), the OP will grow by 30.1% YoY.
Olympus is currently trading at JPY1,251 per share which we believe is overvalued based on our valuation. We believe such a premium is not justified given the governance related issues and the scandals currently faced by the company. Though we expect the company financials to improve, we expect the transformation plan to take a long-time to deliver meaningful changes in the way the company conducts itself.  In our view, the potential for a transformation in governance and business practices is already fully-discounted in the share price.


Olympus: FY03/19 Affected by One-Time Expenses; Yet to See Any Major Change in Culture

Japan

Hoya Corp manufactures electro-optics products such as mask blanks for semiconductors, photomasks for LCD panels, optical glasses, glass memory disks for HDDs, medical flexible endoscopes, eyeglasses, and contact lenses. The Company also provides information system architecture.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Hoya Corp (7741 JP)

Olympus: Key Businesses Continue to Grow; Shares Are Fairly Valued

Olympus (7733 JP) reported 1QFY03/2020 results on Friday (02nd August 2019) which saw a marginal YoY improvement in company revenue while operating...

Shifara Samsudeen, FCMA, CGMA

🇯🇵 JAPAN • Market Update - Levitating on Thin Air

MOVING AVERAGE BREAKOUT - Japanese equities have now risen by 5.1% since the low of 4th June and, since July 1st, the Total Market Value has...

Campbell Gunn

🇯🇵 JAPAN • Spring Results & Revision Scores - Peer Groups

INTRODUCTION - Following on from our review of Spring Market & Sector Aggregates & Scores Insight, this Insight will cover the...

Campbell Gunn

Fujifilm Continues to Increase Its Focus on Healthcare Sector Through the Acquisition of Medwork

On Thursday (16th May), Fujifilm (4901 JP) announced that it has entered into an agreement to acquire medwork GmbH, headquartered in Bayern,...

Shifara Samsudeen, FCMA, CGMA

Olympus: FY03/19 Affected by One-Time Expenses; Yet to See Any Major Change in Culture

Olympus Corporation (7733 JP) reported its full-year FY03/19 results on Friday (10th May). The company reported 0.9% YoY growth in revenue for...

Shifara Samsudeen, FCMA, CGMA

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)